Summary
70 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 50% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Out of every 100 USD of revenue, only 7.7 USD is left as net profit.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 9.8 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.8% a year over 5 years. Over the last 3 years it grew by 13% a year. Earnings per share grew by 50% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 51 USD
- Sales and administration 41 USD
- Taxes and other 0.3 USD
- Net profit 7.7 USD
Net profit, industry median (Insurance - Reinsurance) 9.9 USD
Out of every 100 USD of revenue, 7.7 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.